SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Ali H. Ellebedy(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Alem Haile(Washington University in St. Louis), Charles Goss(Washington University in St. Louis), Adriana M. Rauseo(Washington University in St. Louis), Iskra Pusic(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Elizaveta Kalaidina(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Michael K. Klebert(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Lena Hansen(Washington University in St. Louis), Wooseob Kim(Korea University)
Cited by 33
Related Papers
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783